Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Episode 17 with Dr. Hans Lassmann on the usefulness of animal models for studying multiple sclerosis.
Masitinib mesylate application for conditional approval
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
Keystone Symposium: Dendritic Cells and Macrophages Reunited
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
Episode 4 with Dr. Michael Racke on the Kir4.1 potassium channel
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
American Academy of Neurology Annual Meeting
Second International Porto Congress of Multiple Sclerosis
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
Keystone Symposium: Viral Immunity
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
“Veterinary Medicines” page
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
The Fourth International Conference on Regulatory T Cells and TH Subsets and Clinical Applications in Human Disease
National MS Society: Research Grants
Episode 35 with Dr. Daniel Reich on neuroradiology in MS
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
NYSCF Webinar Series: Multiple Sclerosis and the Promise of Stem Cell Research
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
MS Frontiers 2015
Interleukin-1beta promotes repair of the CNS.
Pages
« first
‹ previous
…
55
56
57
58
59
60
61
62
63
…
next ›
last »
